- Report
- October 2024
- 184 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- January 2025
- 153 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- September 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 265 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- August 2024
- 131 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- February 2024
- 202 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- October 2022
- 194 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2020
- 217 Pages
Global
From €3818EUR$4,000USD£3,199GBP
- Report
- January 2024
- 213 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- August 2022
- 105 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2023
- 178 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 326 Pages
China
From €3818EUR$4,000USD£3,199GBP
- Report
- July 2024
- 187 Pages
China
From €1718EUR$1,800USD£1,439GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2815EUR$2,950USD£2,359GBP
- Report
- September 2023
- 112 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- October 2023
- 114 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2022
- 258 Pages
Global
From €3407EUR$3,570USD£2,855GBP

The Tetanus Vaccine is a vaccine used to protect against tetanus, a serious and potentially fatal bacterial infection. It is usually administered as a single dose, and is recommended for all children and adults. The vaccine is typically given in combination with other vaccines, such as the diphtheria and pertussis vaccines. The Tetanus Vaccine market is a subset of the larger Vaccines market, which is composed of a variety of vaccines used to protect against a range of diseases. Vaccines are typically developed and manufactured by pharmaceutical companies, and are then distributed to healthcare providers and patients.
The Tetanus Vaccine market is highly competitive, with a number of companies offering their own versions of the vaccine. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more